Kelsay is the President and CEO of the Business Group on Health. She predicts that in 2024, employers will "sound the drug price alarm."
We asked our readers and some members of our editorial advisory board to make predictions for 2024. Here's what Ellen Kelsay had to say:
“Healthcare costs will continue to soar, bringing heightened vigilance by employers as well as concerns about the affordability of medications and medical services. Employers will express growing alarm over the sustainability of and lack of transparency into drug pricing. One hundred percent of employers surveyed have some level of concern related to prescription drug trend, which is greatly fueling overall healthcare trend, according to our 2024 Large Employer Health Care Strategy Survey. Employers will place heightened expectations on their partners to deliver, in large part because of considerations regarding cost, quality and outcomes.”
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen